Literature DB >> 22173442

Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients.

Wiesława Kwiatkowska1, Brygida Knysz, Justyna Drelichowska-Durawa, Marcin Czarnecki, Jacek Gąsiorowski, Ewa Biłyk, Maciej Karczewski, Wojciech Witkiewicz.   

Abstract

BACKGROUND: HIV infected patients, especially those treated with antiretroviral (ARV) drugs, show an increased risk and incidence of cardiovascular disease.
OBJECTIVES: The aim of this study was to evaluate the progression of subclinical atherosclerosis in the carotid arteries, expressed as the value of carotid intima-media thickness (cIMT) and the amount of atherosclerotic plaques, and to analyze the correlation between cIMT and risk factors for cardiovascular diseases in a cohort of HIV infected patients.
METHODS: The analysis included 72 HIV infected patients, mean age 39.4 years, and 27 healthy HIV negative individuals, matched for age and sex. The data collected included evaluation of the infection, ARV treatment, past cardiovascular events, assessment of traditional and nontraditional risk factors for cardiovascular diseases, cIMT measurements and amount of atherosclerotic plaques in the carotid arteries.
RESULTS: HIV infected patients show more advanced subclinical atherosclerosis in the carotid arteries (cIMT and plaques incidence). The cardiovascular risk profile of the HIV infected patients is significantly different from HIV negative people. Among the HIV positive group lower body mass index (BMI) and higher waist/hip ratio (WHR) are observed. The concentration of all cholesterol fractions is lower, whereas the concentration of triglycerides is higher. Cigarette smoking is more common among HIV-infected individuals. A strong statistical correlation between cIMT and age, hypertension, non-high-density lipoprotein (non-HDL) cholesterol and ARV time were found. Total and LDL cholesterol, and lifetime smoking exposure also affect the cIMT. The relationship between cIMT and current HIV RNA may indicate the impact of the current infection status on the cIMT dynamics in this subpopulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173442     DOI: 10.5604/17322693.967075

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  7 in total

1.  Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study.

Authors:  Christina M Parrinello; Alan L Landay; Howard N Hodis; Stephen J Gange; Philip J Norris; Mary Young; Kathryn Anastos; Phyllis C Tien; Xiaonan Xue; Jason Lazar; Lorie Benning; Russell P Tracy; Robert C Kaplan
Journal:  Atherosclerosis       Date:  2012-10-05       Impact factor: 5.162

Review 2.  Effects of smoking on non-AIDS-related morbidity in HIV-infected patients.

Authors:  Daniel K Shirley; Robert J Kaner; Marshall J Glesby
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

3.  Peripheral arterial disease and ankle-brachial index abnormalites in young and middle-aged HIV-positive patients in lower Silesia, Poland.

Authors:  Wiesława Kwiatkowska; Brygida Knysz; Katarzyna Arczyńska; Justyna Drelichowska; Marcin Czarnecki; Jacek Gąsiorowski; Maciej Karczewski; Wojciech Witkiewicz
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

4.  Assessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa: a cross sectional study.

Authors:  Felistas Mashinya; Marianne Alberts; Jean-Pierre Van Geertruyden; Robert Colebunders
Journal:  AIDS Res Ther       Date:  2015-12-10       Impact factor: 2.250

5.  The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV.

Authors:  Katarzyna Barska; Wiesława Kwiatkowska; Brygida Knysz; Katarzyna Arczyńska; Maciej Karczewski; Wojciech Witkiewicz
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

6.  Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.

Authors:  Agnieszka Pawlos; Marlena Broncel; Ewelina Wlazłowska; Elżbieta Jabłonowska; Paulina Gorzelak-Pabiś
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

Review 7.  A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management.

Authors:  Mansueto Gomes Neto; Ricardo Zwirtes; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2013-07-31       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.